TCL Archive Also in this 8-page issue: Cooperative groups tell Congress that NCI’s $115 million in support for adult cancer clinical trials is “chump change.” Trials would close faster, report results sooner, if funding were increased, regulatory issues streamlined. May 28, 2004
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels October 25, 1985
TCL Archive Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse August 12, 1988
TCL Archive CCOP RFA Issued; ‘Chop-Like’ Elements Permitted But Not Required; No ‘Cap’; Consortia Allowed July 16, 1982
